Targeting gp100 and TRP-2 with a DNA vaccine: Incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with favourable clinical outcome in a phase I/II trial

DOI: 10.1080/2162402X.2018.1433516

Keywords: Immunotherapy, vaccine, melanoma, T-cell

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text